investing-statsSEC Form 4 insider transactions

Insider trades

SEC Form 4 · reported within 2 business days

174,837 transactions stored · last updated 2026-09-11 02:40:03 UTC · export this view: JSON · CSV · RSS

Filter transactions
Reset
Open-market buysOpen-market sellsBuys $1M+Sells $1M+Discretionary sells10b5-1 plan sellsDirector trades10% owners
Filtered byTicker: TRAX Clear all
MatchesEvery transaction matching the current filters, including grants, gifts, and exercises.133
BuysPurchases that moved money (value > $0) and their total. Grants, gifts, and $0 conversions are excluded from the dollar flow.2 / $65.23M
SellsSales that moved money (value > $0) and their total. Trades with no stated price are excluded from the dollar flow.1 / $1.76M
Net flowBuy value minus sell value across the priced trades above. Positive = net buying, negative = net selling.$63.47M
$65.23M bought$1.76M sold ▼

Cluster activity: 2 or more insiders trading the same stock on the open market in the last 30 days (146 buy / 670 sell)

Stocks with two or more insiders trading the same way on the open market in the last 30 days
SideTickerCompanyInsidersTradesTotal
buyTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTD3034$295.9K
buyNONEWILSON BANK HOLDING CO1925$95.64M
buyN/AJohn Hancock GA Senior Loan Trust910$80.79M
buyCDNLCardinal Infrastructure Group Inc.713$8.54M
buyAMRZAmrize Ltd711$1.94M
buyCODICompass Diversified Holdings68$2.43M
buyWIXWix.com Ltd.68$185.7K
buyACONAclarion, Inc.66$125.7K
buyLIENChicago Atlantic BDC, Inc.518$1.22M
buyGPUSHyperscale Data, Inc.517$1.05M
buyDKLDelek Logistics Partners, LP55$750.0K
buyBWFGBankwell Financial Group, Inc.517$602.7K
buyBMRABIOMERICA INC55$158.0K
buyGMEGameStop Corp.44$21.71M
buyINVInnventure, Inc.44$807.8K
buyAMRCAmeresco, Inc.49$738.4K
buyTISITEAM INC48$621.6K
buyEMBCEmbecta Corp.44$557.9K
buyFOCLEDAP TMS SA44$408.5K
buyUAMYUNITED STATES ANTIMONY CORP44$298.7K

Most active insiders by open-market value in the last 30 days

· net API
Most active insiders by open-market value in the last 30 days
InsiderRoleTickersTradesBoughtSoldNet
Magnetar Financial LLC; Magnetar Capital Partners LP; Supernova Management LLC; Snyderman David J.10% owner; 10% owner; 10% owner; 10% owner1138$0$253.01B$-253.01B
WIRTH JAMES FOfficer (President & CEO), 10% owner, Chairman14$0$3.66B$-3.66B
CASCADE INVESTMENT, L.L.C.; GATES WILLIAM H III10% owner; 10% owner171$1.14B$0$1.14B
Chu James MichaelDirector11$0$1.10B$-1.10B
STEVENS MARK ADirector114$0$646.48M$-646.48M
BDT CAPITAL PARTNERS, LLC; BDTCP GP II-A, L.P.; BDTCP GP II, Co.; BDT Badger Holdings, LLC; BDTP GP, LLC; Trott Byron D; BDTCP GP II-A (DEL), LLCDirector, 10% owner; Director, 10% owner; Director, 10% owner; Director, 10% owner; Director, 10% owner; Director, 10% owner; Director, 10% owner11$0$589.61M$-589.61M
Uber Technologies, Inc10% owner11$0$471.60M$-471.60M
DST Global Advisors Ltd; DST Global VI, L.P.; DST Global VII, L.P.; DST Investments XXI, L.P.; DSTG VI Investments, L.P.; DSTG VI Investments-A, L.P.; DSTG VII Investments-1, L.P.; DSTG VII Investments-4, L.P.; DST Managers VI Ltd; DST Managers VII Ltd10% owner; 10% owner; 10% owner; 10% owner; 10% owner; 10% owner; 10% owner; 10% owner; 10% owner; 10% owner191$0$324.97M$-324.97M
DST Global Advisors Ltd; Cardew Services Ltd; Galileo (PTC) Ltd; Zinonos Despoina10% owner; 10% owner; 10% owner; 10% owner191$0$324.97M$-324.97M
Meister Keith A.Director153$0$288.00M$-288.00M
SLTA V (GP), L.L.C.; Silver Lake Group, L.L.C.; Silver Lake Technology Associates V, L.P.; SLP Fastball Aggregator, L.P.; Osnoss Joseph; SLP V Aggregator GP, L.L.C.Director, 10% owner; Director, 10% owner; Director, 10% owner; Director, 10% owner; Director; Director, 10% owner11$0$275.19M$-275.19M
Ignition Acquisition Holdings LP; Ignition Acquisition Holdings GP LLC; Ignition Parent LP; Ignition GP LLC; Ignition Topco Ltd; Apax X GP Co. Ltd; Apax Guernsey (Holdco) PCC Ltd10% owner; 10% owner; 10% owner; 10% owner; 10% owner; 10% owner; 10% owner11$0$274.88M$-274.88M
ARES MANAGEMENT LLC; Ares Partners Holdco LLC; Ares Voting LLC; Ares Management GP LLC; Ares Management Corp; Ares Holdco LLC; Ares Management Holdings L.P.10% owner; 10% owner; 10% owner; 10% owner; 10% owner; 10% owner; 10% owner11$0$235.75M$-235.75M
ARES MANAGEMENT LLC; ACOF Investment Management LLC; Ares Corporate Opportunities Fund V, L.P.; ASSF Operating Manager IV, L.P.; ASSF IV AIV B Holdings III, L.P.; ASSF IV AIV B, L.P.; ASOF Investment Management LLC; ASOF Holdings I, L.P.10% owner; 10% owner; 10% owner; 10% owner; 10% owner; 10% owner; 10% owner; 10% owner11$0$235.75M$-235.75M
BERTARELLI ERNESTO; KC Armada LP10% owner; 10% owner11$219.00M$0$219.00M

Sector flows: net open-market value by industry in the last 30 days

· JSON
Net open-market insider value by industry in the last 30 days
IndustryTickersTradesBoughtSoldNet flow
Services-Prepackaged Software981558$805.0K$254.31B$-254.31B
Real Estate Investment Trusts53182$33.03M$3.70B$-3.67B
Semiconductors & Related Devices46600$984.6K$1.31B$-1.31B
Refuse Systems583$1.14B$2.84M$1.14B
Footwear, (No Rubber)22$0$1.10B$-1.10B
Finance Services44426$24.71M$714.43M$-689.73M
Pharmaceutical Preparations143930$148.62M$817.84M$-669.23M
Refrigeration & Service Industry Machinery616$1.44M$597.13M$-595.68M
Services-Home Health Care Services221$0$560.13M$-560.13M
Services-Computer Integrated Systems Design1372$3.99M$531.78M$-527.79M
Retail-Miscellaneous Retail646$0$483.60M$-483.60M
Electronic Computers4360$0$407.12M$-407.12M

How to read this

Filed
Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
Ticker
The issuer's stock symbol. Select it to open that company's insider-activity page.
Issuer
The company whose shares were traded.
Sector
The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
Insider
The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
Role
The insider's relationship to the company: director, officer, or 10% owner.
Code
SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
Side
Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
10b5-1
Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
Shares
Number of shares in this transaction.
Price
Reported price per share. Blank for grants, gifts, and other trades with no stated price.
Value
Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
Owned after
Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
Own Δ
How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
Co. Δ
Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
D/I
Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
Lag
Days from the trade date to the filing date (Form 4 is due within 2 business days).

Transaction codes

Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.

P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award or other acquisition pursuant to Rule 16b-3(d)
D
Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
F
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
M
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
G
Bona fide gift
C
Conversion of derivative security
X
Exercise of in-the-money or at-the-money derivative security
J
Other acquisition or disposition (describe transaction)
Insider transactions matching the current filters
FiledDate the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.TickerIssuerSectorIssuer's industry (SEC SIC classification). Select a value in the table to filter to that sector.InsiderRoleCodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S), the highest-conviction signal.SideDirection of the trade, from the filing: a buy (acquired ▲) or a sell (disposed ▼).SharesNumber of shares in this transaction.PriceReported price per share. Blank for grants, gifts, and other trades with no stated price.ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).Owned afterShares the insider held (directly or indirectly) immediately after this trade.Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable.D/IOwnership form: D = direct, I = indirect (for example, held through a trust, fund, or family member).LagDays from the trade date to the filing date (Form 4 is due within 2 business days).Link to SEC filing
2026-09-04TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsWare J. AnthonyDirectorM sell10,694 10,694 Common Stock0D3dfiling
2026-09-04TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsWare J. AnthonyDirectorM sell28,571 28,571 Common Stock0D3dfiling
2026-09-04TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsWare J. AnthonyDirectorS sell39,2650$44.78$1.76M15,660−71%−0.11% (now 0.04%)D3dfiling
2026-09-04TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsWare J. AnthonyDirectorM buy39,2650$5.74$225.4K54,9253.5×+0.11% (now 0.15%)D3dfiling
2026-08-18TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsSTONE BENJAMINOfficer (Chief Business Officer)A buy60,492 60,492 Common Stock137,651D3dfiling
2026-08-18TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsLizzul Paul F.Officer (Chief Medical Officer)A buy60,492 60,492 Common Stock137,651D3dfiling
2026-08-18TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsFaga DanielDirector, Officer (President, CEO)A buy193,575 193,575 Common Stock440,485D3dfiling
2026-08-05TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsSTONE BENJAMINOfficer (Chief Business Officer)A buy60,492 60,492 Common Stock77,159D4dfiling
2026-08-05TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsLizzul Paul F.Officer (Chief Medical Officer)A buy60,492 60,492 Common Stock77,159D4dfiling
2026-08-05TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsFaga DanielDirector, Officer (President, CEO)A buy193,576 193,576 Common Stock387,156D4dfiling
2026-06-17TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsWare J. AnthonyDirectorM sell6,030 6,030 Common Stock0D2dfiling
2026-06-17TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsWare J. AnthonyDirectorM buy6,030015,660+63%+0.02% (now 0.04%)D2dfiling
2026-06-17TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsJain RitaDirectorM sell1,300 1,300 Common Stock0D2dfiling
2026-06-17TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsJain RitaDirectorM sell6,030 6,030 Common Stock0D2dfiling
2026-06-17TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsJain RitaDirectorM buy7,330019,194+62%+0.02% (now 0.05%)D2dfiling
2026-06-17TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsMarquet MagdaDirectorM sell6,030 6,030 Common Stock0D2dfiling
2026-06-17TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsMarquet MagdaDirectorM buy6,030015,960+61%+0.02% (now 0.04%)D2dfiling
2026-06-17TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsSchmid John P.DirectorM sell6,030 6,030 Common Stock0D2dfiling
2026-06-17TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsSchmid John P.DirectorM buy6,030037,652+19%+0.02% (now 0.11%)D2dfiling
2026-06-17TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsOrwin John ADirectorM sell6,030 6,030 Common Stock0D2dfiling
2026-06-17TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsOrwin John ADirectorM buy6,030016,695+57%+0.02% (now 0.05%)D2dfiling
2026-06-17TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsFENTON DENNIS MDirectorM sell6,030 6,030 Common Stock0D2dfiling
2026-06-17TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsFENTON DENNIS MDirectorM buy6,030010,9952.2×+0.02% (now 0.03%)D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsSTONE BENJAMINOfficer (Chief Business Officer)A buy72,300 72,300 Common Stock72,300D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsSTONE BENJAMINOfficer (Chief Business Officer)A buy26,700 26,700 Common Stock26,700D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsTamboli AjimOfficer (Chief Financial Officer)A buy13,600 13,600 Common Stock13,600D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsTamboli AjimOfficer (Chief Financial Officer)A buy5,000 5,000 Common Stock5,000D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsWare J. AnthonyDirectorA buy42,000 42,000 Common Stock42,000D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsWare J. AnthonyDirectorA buy15,000 15,000 Common Stock15,000D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsLizzul Paul F.Officer (Chief Medical Officer)A buy72,300 72,300 Common Stock72,300D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsLizzul Paul F.Officer (Chief Medical Officer)A buy26,700 26,700 Common Stock26,700D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsJain RitaDirectorA buy42,000 42,000 Common Stock42,000D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsJain RitaDirectorA buy15,000 15,000 Common Stock15,000D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsMarquet MagdaDirectorA buy42,000 42,000 Common Stock42,000D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsMarquet MagdaDirectorA buy15,000 15,000 Common Stock15,000D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsSchmid John P.DirectorA buy42,000 42,000 Common Stock42,000D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsSchmid John P.DirectorA buy15,000 15,000 Common Stock15,000D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsOrwin John ADirectorA buy42,000 42,000 Common Stock42,000D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsOrwin John ADirectorA buy15,000 15,000 Common Stock15,000D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsFaga DanielDirector, Officer (President, CEO)A buy271,100 271,100 Common Stock271,100D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsFaga DanielDirector, Officer (President, CEO)A buy100,200 100,200 Common Stock100,200D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsFENTON DENNIS MDirectorA buy42,000 42,000 Common Stock42,000D2dfiling
2026-05-14TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsFENTON DENNIS MDirectorA buy15,000 15,000 Common Stock15,000D2dfiling
2026-04-23TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsTamboli AjimOfficer (Chief Financial Officer)A buy41,234 41,234 Common Stock41,234D0dfiling
2026-04-23TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsTamboli AjimOfficer (Chief Financial Officer)A buy41,233 41,233 Common Stock41,233D1dfiling
2026-04-23TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsTamboli AjimOfficer (Chief Financial Officer)A buy41,233 41,233 Common Stock41,233D2dfiling
2026-04-23TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsTamboli AjimOfficer (Chief Financial Officer)A buy45,700 45,700 Common Stock45,700D2dfiling
2026-04-22TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsWare J. AnthonyDirectorA buy4,000 4,000 Common Stock4,000D2dfiling
2026-04-22TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsWare J. AnthonyDirectorA buy6,030 6,030 Common Stock6,030D2dfiling
2026-04-22TRAXFirst Tracks Biotherapeutics, Inc.Pharmaceutical PreparationsWare J. AnthonyDirectorA buy5,500 5,500 Common Stock5,500D2dfiling

Open “How to read this” above for definitions of every column and code. Select a column heading to sort.